$300 Million is the total value of Column Group LLC's 7 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines Inc | $109,044,149 | +20.8% | 4,577,840 | 0.0% | 36.30% | +81.7% | |
| NGM | NGM Biopharmaceuticals Inc | $91,046,410 | -61.6% | 18,136,735 | 0.0% | 30.31% | -42.3% | |
| RAPT | Buy | RAPT Therapeutics Inc | $53,076,296 | -17.7% | 2,680,621 | +0.0% | 17.67% | +23.8% |
| ORIC | ORIC Pharmaceuticals Inc. | $21,016,586 | +84.1% | 3,568,181 | 0.0% | 7.00% | +176.9% | |
| Tenaya Therapeutics, Inc. | $18,894,583 | -30.7% | 9,400,290 | 0.0% | 6.29% | +4.2% | ||
| Buy | Surrozen, Inc. | $5,478,469 | -70.7% | 9,414,795 | +1.8% | 1.82% | -55.9% | |
| eFFECTOR Therapeutics Inc | $1,842,669 | -25.2% | 4,309,329 | 0.0% | 0.61% | +12.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | 12 | Q3 2023 | 52.5% |
| Revolution Medicines Inc | 12 | Q3 2023 | 36.3% |
| RAPT Therapeutics Inc | 12 | Q3 2023 | 29.6% |
| ORIC Pharmaceuticals Inc. | 12 | Q3 2023 | 14.6% |
| Tenaya Therapeutics, Inc. | 9 | Q3 2023 | 24.2% |
| Surrozen, Inc. | 9 | Q3 2023 | 8.2% |
| eFFECTOR Therapeutics Inc | 9 | Q3 2023 | 6.9% |
| Constellation Pharmaceuticals Inc. | 3 | Q2 2021 | 12.6% |
| Nurix Therapeutics Inc | 2 | Q1 2021 | 16.1% |
| Gritstone Oncology Inc | 1 | Q4 2020 | 0.3% |
View Column Group LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 4 | 2022-05-27 |
| 4 | 2022-05-25 |
| 13F-HR | 2022-05-16 |
View Column Group LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.